|
Indian Pediatr 2018;55:871-873 |
|
Pediatric Budd-Chiari
Syndrome: A Case Series
|
Rajeev Redkar, Anant Bangar, Varun Hathiramani, Vinod
Raj and C Swathi
From Department of Pediatric Surgery, Lilavati
Hospital and Research Centre, Mumbai, Maharashtra, India.
Correspondence to: Dr Rajeev G Redkar, Consultant
Pediatric Surgeon, Lilavati Hospital and Research Centre, Mumbai,
Maharashtra, India.
Email: [email protected]
Received: December 13, 2016;
Initial review: May 06, 2017;
Accepted: July 30, 2018.
|
Objective: To
study the diagnostic methods and treatment outcomes in children with
Budd- Chiari syndrome. Methods: Case records of 25 patients with
Budd-Chiari syndrome were evaluated retrospectively. These patients were
investigated with imaging techniques and underwent balloon angioplasty
or surgical management. Results: 21 patients underwent balloon
angioplasty, of which 17 had good medium- to long-term results, while
only one out of four patients who underwent a portocaval shunt survived.Conclusion:
The balloon angioplasty has satisfactory outcome in the treatment of
acute Budd-Chiari syndrome. In failed cases, the surgical therapy may be
attempted, but the outcomes do not appear rewarding.
Keywords: Balloon angioplasty, Outcome, Treatment, Venous
thrombosis.
|
B udd-Chiari syndrome (BCS) is a heterogeneous
group of clinical conditions presenting with hepatic venous outflow
obstruction from the level of the hepatic veins to the junction of the
inferior vena cava (IVC) with the right atrium [1]. The causes of venous
obstruction in children are many [1-3], with hypercoagulable state being
the most common. Clinical manifestations in many cases are nonspecific,
and high index of suspicion with imaging may be critical for early
diagnosis of hepatic venous obstruction and accurate assessment of the
extent of disease. The data regarding pediatric BCS are scarce, and the
treatment strategies are not well defined. We describe our experience
with diagnostic methods and outcome of the endovascular and surgical
therapies in children with BCS managed at our center.
Methods
The case records of children (age
£12 y) diagnosed as
BCS during January 2000 to January 2016 at our center were
retrospectively reviewed. All these patients were diagnosed based on
their clinical features, radiological investigations and angiographic
findings. After relevant clinical examination, patients were further
evaluated with laboratory and radiological investigations. Blood tests
were aimed at finding the etiological factor, evaluating the extent of
hepatic decompensation and ascertaining the fitness for the therapeutic
procedure. Blood investigations were; complete blood count, liver
function test, renal function test, coagulation profile and
investigation for causative factors. A baseline abdominal
ultrasonography along with color Doppler ultrasound using ‘M mode’ was
performed in most patients. If color Doppler was suggestive of BCS,
diagnosis was confirmed with computed tomography (CT) or magnetic
resonance (MR) hepatic venous angiogram. Conventional angiography was
performed under general anesthesia.
The initial therapeutic approach was transjugular in
all cases via internal jugular puncture or by railroading over
IVC catheter that was introduced till the right internal jugular vein
through femoral puncture. In selected cases where this approach failed,
further attempts were made via a transhepatic route with
insertion of a percutaneous transhepatic guidewire with railroading of
catheter through transjugular route. With transjugular or rarely
transhepatic wire in place, the balloon angioplasty was performed to
achieve the patency of hepatic veins and IVC. Liver biopsy was performed
at the end of angiography procedure under same anesthesia using trucut
biopsy gun. Angioplasty was considered to be successful if restoration
of or clear improvement in hepatic venous outflow was shown by contrast
angiography, and symptomatic improvement. Post-procedure, patients were
treated with intravenous heparin, which was tapered gradually. Patency
and improvement was assessed with Doppler ultrasound and liver function
tests. Patients were started on oral warfarin or subcutaneous low
molecular weight heparin injections simultaneously when intravenous
heparin was tapered. Adequacy of anticoagulation therapy was monitored
with measurement of prothrombin time and activated partial
thromboplastin time. Oral anticoagulation was continued for at least one
year. If patency was not demonstrated on Doppler ultrasound, the
patients were posted for porto-caval shunt surgery if liver biopsy
showed non-cirrhotic change, and were referred to liver transplantation
surgery, if liver was cirrhotic.
Results
We evaluated records of 25 children (14 boys).
Abdominal distension was the most common presenting symptom seen in 20
patients followed by associated or preceding loose motions in 8
patients. Other symptoms seen were poor feeding (n=2), limb
swelling/edema (n=3), fever (n=3), and inguino-scrotal
swelling, abdominal pain, lower limb pain, vomiting and respiratory
distress in one patient each. Color Doppler was performed in 18 patients
and could diagnose hepatic vein obstruction in 15 patients. In 3
patients, diagnosis of hepatic venous obstruction was missed on color
Doppler and was diagnosed by MR angiography (n=1) or conventional
hepatic/IVC angiography (n=2). CT scan with CT hepatic venous
angiography was performed in 11 patients and MR angiography was done in
9 patients, of which 3 patients had both CT scan and MR angiography. In
20 patients, the site of obstruction was convincingly diagnosed by
radiological investigations (Doppler ultrasound or CT angiography or MR
angiography), whereas these investigations failed to delineate site of
obstruction in five patients. In these five patients, hepatic/IVC
angiography convincingly diagnosed a hepatic venous/IVC obstruction.
Hepatic-IVC angiogram was performed in 21 patients
and antegrade flow was established successfully in 20 patients. In all
the patients one or more hepatic veins were obstructed, and in five
patients IVC was obstructed in addition to hepatic veins. In one of
these patients, transjugular approach failed and hence transhepatic
route was used, while in one other patient jugular as well as
transhepatic route failed. Of the four patients who did not undergo
hepatic/IVC angiography, two showed spontaneous resolution of symptoms
and two patients died. Four patients underwent portocaval shunting with
H-portocaval jump graft; one survived while three died. Three patients
out of 20 patients in whom flow was established after successful
angioplasty, developed recurrence of symptoms after few months. All
these three patients underwent portovenous shunt surgery, of which two
died in late postoperative period. Overall, out of 25 patients, 17
patients recovered and survived while eight patients died. Two died
before any intervention could be done, one died (post-shunt surgery)
after failed attempt at angioplasty, and five died due to other reasons
(two post-shunt surgery, one each with sepsis following lower
respiratory tract infection and pulmonary hemorrhage, and cause was not
known in one patient as patient did not follow-up) following successful
angioplasty. Of the 15 available liver biopsy reports, four patients
showed changes of cirrhosis and were referred for liver transplantation
and the remaining 11 patients who showed no changes of liver cirrhosis,
7 responded well to venoplasty treatment and were continued on
anticoagulation. Four patients who showed noncirrhotic changes and did
not respond to venoplasty intervention eventually underwent
portosystemic shunt surgery.
Discussion
In this hospital record review of 25 patients of BCS,
we could achieve flow in atleast one hepatic vein in 20 (95%) out of 21
procedures and were able to maintain patency in 17 (80%) of these
patients. Overall there were 8 deaths, out of which 5 were in those in
whom flow in hepatic veins was achieved.
The major limitation in our study is an uncontrolled
design and lack of comparison of hepatic balloon angioplasty with venous
stents. We believe that the hepatic venous stents may be difficult to
place in young infants and children; they have risk of migration and are
prone for blockage requiring prolonged life-long anticoagulation.
Similarly, our policy was to proceed with either portovenous surgical
shunt or refer to liver transplant in failed balloon angioplasties
depending on the liver histology. Hence we lack comparison with
transhepatic portacaval shunt (TIPPS) or direct intrahepatic portacaval
shunt (DIPS). Moreover, a hypercoagulable state is expected in patients
with BCS, but we could not perform relevant work-up in our series.
Interventional radiological procedures for BCS are
described in adults but literature on this modality in pediatric age
group is scarce [4,5]. Miller, et al. [6] studied imaging with
pathological findings in 21 patients and concluded that each imaging
modality offers certain values and limitations in the assessment of
vascular or parenchymal findings in BCS. In this study, status of
hepatic veins was correctly assessed and correlated with pathology in 13
of 20 patients who had sonograms, in 12 of 15 patients who had MRI, and
in nine of 18 patients with contrast-enhanced CT scans [6]. In our study
also, all three modalities along with hepatic angiography were used for
diagnosis.
The primary goal of treatment is the resolution of
hepatic congestion in order to improve liver perfusion and preserve
functioning hepatocytes. If medical therapy fails, then valuable time to
salvage the functioning liver may be lost. Hence we used aggressive
early use of interventional radiology. Recanalization of stenotic or
occluded hepatic veins to restore venous outflow is the initial
procedure of choice [5]. Various approaches may be used to access the
hepatic veins. Transjugular catheterization by internal jugular vein
puncture or railroading over IVC catheter through femoral puncture is
attempted first. If the stenotic or occluded hepatic vein cannot be
crossed by using a transjugular approach, an ultrasound-guided
transhepatic needle puncture of a patent segment of the hepatic vein is
performed to obtain access [6-8]. In one of our patient, transhepatic
access was used successfully for hepatic venous angiography, while even
this approached failed in one patient. Balloon angioplasty had good
results in our series. In patients with failed endovascular approach,
surgical therapy of portocaval shunting was attempted if liver was
congested and noncirrhotic. Our results of surgical therapy were not
rewarding as only one out of four such patients survived.
To conclude, early aggressive use of interventional
radiological procedure may achieve successful diagnosis and
recanalization in most children with BCS. In failed cases, the surgical
therapy may be attempted, but the outcomes do not seem to be rewarding.
If the access for balloon angioplasty is difficult through IJV, it can
be aided by transfemoral or transhepatic approach aggressively.
Contribution: All autors contributed to data
collection, study design and manuscript writing.
Funding: None; Competing interest: None
stated.
What this Study Adds?
• Budd-Chiari syndrome may have good outcome
if treated early with hepatic/ inferior vena cava venoplasty.
|
References
1. Aydinli M, Bayraktar Y. Budd-Chiari syndrome:
Etiology, pathogenesis and diagnosis. World J Gastroenterol.
2007;13:2693-6.
2. Suri A, Sharma VK, Ranade PR, Marar S, Nagral A.
Ruptured hepatocellular carcinoma in a children with Budd-Chiari
syndrome. Indian Pediatr. 2016;53:833-4.
3. Kaur J, Gupta A, Wadhwa N. Hepatic visceral larva
migrans causing hepatic venous thrombosis and prolonged fever. Indian
Pediatr. 2017;54:882-4.
4. Valla DC. Prognosis in Budd Chiari syndrome after
re-establishing hepatic venous drainage. Gut. 2006;55:761-3.
5. Nagral A, Hasija RP, Marar S, Nabi F. Budd-Chiari
syndrome in children: Experience with therapeutic radiological
intervention. J Pediatr Gastroenterol Nutr. 2010;50:74-8.
6. Miller WJ, Federle MP, Straub WH, Davis PL. Budd-Chiari
syndrome: Imaging with pathologic correlation. Abdom Imaging.
1993;18:329-35.
7. Fisher NC, McCafferty I, Dolapci M, Wali M,
Buckels JA, Olliff SP, et al. Managing Budd-Chiari syndrome: A
retrospective review of percutaneous hepatic vein angioplasty and
surgical shunting. Gut. 1999;44:568-74.
8. Cooper S, Olliff SP, Elias E. Recanalisation of
hepatic veins by a combined transhepatic, transjugular approach in three
cases of Budd Chiari syndrome. Clin Radiol.1994; 49:743-3.
|
|
|
|